Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-006263

CVP, TAVR sold 619 shares at $91.40 ($56,577)

  • CVP, TAVR acquired 619 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Lippis Daniel J. CVP, TAVR 2026-06-30 Option exercise 10b5-1 +619 $72.68 $44,989 41,029.91 D
Lippis Daniel J. CVP, TAVR 2026-06-30 Sale 10b5-1 −619 $91.40 $56,577 40,410.91 D
Derivatives
Lippis Daniel J. CVP, TAVR 2026-06-30 Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 −619 5,571 D
Open-market sales · 619 sh · avg $91.40 · $56,577
Loading xslF345X06/doc4.xml…